600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01563

Synthetic patientNBL-101 · Day 120 · 65–74 · F · baseline S02Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S02
  2. Day 91 HY-01 recommended — Hydration Protocol HY-01
  3. Day 92 Patient accepted — Started HY-01 in the companion
  4. Day 96 No meaningful change — Hydration Protocol HY-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Inflammatory activity-7
  • Toxicity-7
  • GI instability-5
  • Treatment adherence-4
  • Nutritional resilience+2

What helped?

  • Hydration Protocol HY-01Day 91
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
22.4/100
worsening · +5.1 vs previous 14 d
Toxicity
Blood
11.4/100
improving · -6.0 vs previous 14 d
Sleep quality
Wearable
62.6/100
stable · -0.6 vs previous 14 d
Energy level
Daily log
6.3/10
stable · -0.0 vs previous 14 d
Stress level
Daily log
4.7/10
worsening · +0.3 vs previous 14 d
Steps
Wearable
7,519
stable · +147 vs previous 14 d
Adherence
Companion
91.1 %
worsening · -5.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 85 from the failing basin, 4 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
Would not help
  • HY-01 Hydration Protocol
    already tried, no meaningful change
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Spicy / capsaicin
    -1.8no signal · 48%
  • Insoluble fibre
    +1.3no signal · 37%
  • Simple carbohydrates
    +0.9no signal · 25%
  • Dietary fat load
    -0.6no signal · 15%
  • Histamine load
    -0.1no signal · 15%
  • Alcohol
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Rapid metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.4 · butyrate capacity 73/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    37 ms
    Sleep
    7.6 h
    Steps
    6,646
    Resting HR
    60 bpm
    Daily log: GI score 22, nutritional resilience 64, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0179854%S08NP-02improved78
    P-0149551%S07BR-03improved85
    P-0165451%S08CR-01improved85
    P-0132949%S08BR-03improved79
    P-0179647%S09SC-12improved86
    P-0179145%S06ME-01improved79
    P-0162544%S06SC-12improved83
    P-0143942%S18ME-01improved79
    P-0167142%S04SC-12improved90
    P-0150341%S15ME-01improved80
    P-0146739%S09HY-01improved79
    P-0147938%S15DT-01improved84